Kayexalate Sodium

Sodium Polystyrene Sulfonate, the active ingredient in Kayexalate Sodium, is an ion‑exchange resin presented as an oral or rectal preparation for oral and rectal use. It is employed to lower elevated serum potassium levels in patients with hyperkalemia, particularly in those with renal impairment or receiving potassium‑sparing therapies.

GNH USA supplies Kayexalate Sodium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies, clinics and other healthcare facilities worldwide.

Kayexalate Sodium is used to manage conditions involving excess potassium in the bloodstream. - Hyperkalemia: reduces serum potassium concentrations to safer levels. - Acute potassium overload: provides rapid potassium removal in emergency settings. - Chronic renal failure‑related hyperkalemia: assists long‑term potassium control when dietary measures are insufficient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Constipation: reduced bowel movements. - Abdominal discomfort: cramping or pain. - Diarrhea: loose stools. - Taste alteration: metallic or salty taste. - Electrolyte imbalance: mild sodium increase.

Serious or Rare Side Effects: - Intestinal necrosis: severe bowel tissue damage. - Colonic perforation: rare but life‑threatening. - Severe hypernatremia: excessive sodium accumulation. - Allergic reactions: rash, itching, swelling. - Metabolic acidosis: abnormal blood pH. - Severe dehydration: due to fluid loss.

Kayexalate Sodium should be used with caution in specific clinical situations. - Renal impairment: monitor potassium and sodium levels closely. - Cardiovascular disease: watch for fluid shifts and electrolyte changes. - Gastrointestinal disorders: avoid in patients with active bowel obstruction or recent GI surgery. - Concomitant potassium‑sparing drugs: adjust dosing to prevent additive effects. - Pregnancy and lactation: use only if clearly needed, as safety data are limited. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Kayexalate Sodium may interact with several medications, requiring careful management. Major Interactions (Avoid): - Sodium polystyrene sulfonate with sorbitol: increased risk of intestinal necrosis. - ACE inhibitors or ARBs: may potentiate hyperkalemia if resin is ineffective. - Digoxin: altered absorption may affect drug levels. Moderate Interactions (Monitor Closely): - Lithium: resin may increase lithium concentrations. - Antacids containing aluminum or magnesium: reduced resin efficacy. - Oral potassium supplements: may diminish potassium‑lowering effect.